Amal Therapeutic is developing a novel cancer vaccine platform that is able to simultaneously (i) stimulate multi-epitopic cytotoxic T cell-mediated immunity, (ii) induce helper T (Th) cells and (iii) promote immunological memory. These 3 parameters are essential to generate potent anti-tumor immunity.